We are aware that a message is circulating on local social media suggesting that Tirzepatide (Mounjaro) will be available for weight loss prescriptions from GPs starting 23rd June. As a result, we have received a high volume of enquiries.
Please note that while the guidance refers to ‘primary care’, this does not mean individual GP practices. We have been explicitly advised not to prescribe this medication.
Find out more about Mounjaro (Tirzepatide) access in Cheshire and Merseyside on the ICB website.
To learn more about how the NHS uses your data read this national data opt-out sheet (PDF).
For further details and information on how to opt out visit www.nhs.uk/your-nhs-data-matters.
Page published: 11 June 2024
Last updated: 12 June 2024